✦ LIBER ✦

P.2.a.032 Paroxetine in the treatment of dysthymic disorder without major depression - efficacy, tolerability, and impact on quality of life

✍ Scribed by A.V. Ravindran; C. Cameron; R. Bhatla; S. Simpson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.020 The impact of treatment on qua

✍ K. Demyttenaere 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The impact of treatment on quality of li

✍ K. Demyttenaere 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 43 KB

P.2.a.034 Impact of methodology on the e

✍ S. Montgomery; A. Kalali; R.S. McIntyre; W.R. Earley; S. Nyberg; H. Eriksson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P.2.c.033 The efficacy of desvenlafaxine

✍ C. Soares; M. Thase; S. Kornstein; C. Brisard; L. Septien-Velez; J.M. Germain; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P.2.c.020 The efficacy and safety of lev

✍ A. Bose; C. Chen; C. Gommoll; A. Ruth; J. Terner-Rosenthal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

P.2.c.006 Efficacy and clinical relevanc

✍ A. Khan; W. Song; J. Edwards; A. Ruth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB